Clients speak
A dedicated team to assist Biocon with their business risk and specialist advisory requirements
Biocon and Grant Thornton India started working together in 2005. At that time the company had just completed a very successful IPO and was also looking to changing their internal auditor from a local to an international Firm.
Kiran Mazumdar shaw states, "When we first met with Grant Thornton India we were looking for a change in our internal auditors. They clearly explained to us the merits of good enterprise risk management and a customized service offering, which would involve the development of a risk charter to be used to create a cost effective business oriented internal audit function.
About Biocon Limited
Biocon is a fully integrated biopharmaceutical enterprise, which focuses on healthcare and is India's largest biotech company. The company apply's exceptional proprietary fermentation technologies and research skills in drug synthesis to succeed in the biopharmaceutical market.